nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2023, 15, v.29 1162-1172
基于网络药理学和实验验证探讨附子治疗变应性鼻炎的作用机制研究
基金项目(Foundation): 海南省自然科学基金项目(820RC627)~~
邮箱(Email): muzhonglin2@sina.com;
DOI: 10.13210/j.cnki.jhmu.20230616.003
发布时间: 2023-06-19
出版时间: 2023-06-19
网络发布时间: 2023-06-19
移动端阅读
摘要:

目的:研究附子治疗变应性鼻炎(allergic rhinitis, AR)的关键作用靶点基因和信号通路。方法:使用TCMPS和PubChem数据库,用口服生物利用度和药物相似度作为筛选条件筛选出附子的活性成分及作用靶点基因,使用GeneCards数据库筛选出AR的靶点基因。利用在线工具Venny2.1筛选出附子治疗AR的作用靶点基因;利用STRING数据库获取药物疾病作用靶点的蛋白互作(Protein-protein interaction, PPI)网络,通过MCC算法找出关键靶点基因。通过GO富集和KEGG富集分析找到潜在的生物学过程和信号通路。最后,进行了动物实验证明附子对AR的治疗作用。结果:使用TCMSP、PubChem和GeneCards数据库筛选出附子中21种活性化合物成分和附子对AR的潜在治疗靶点基因68个。PPI网络分析找出前十个关键靶点基因,分别为:PTGS2、TNF、IL6、AKT1、ALB、STAT3、CCL2、CXCL8、VEGFA和JUN。GO功能和KEGG通路富集分析显示附子对AR的作用靶点显著富集的功能和通路与AR密切相关。最后通过动物实验验证附子对AR的治疗是有效的。结论:AR患者鼻黏膜组织中IL-6和TNF-α的表达增加,与变应性鼻炎疾病活动相关指标呈正相关。附子通过抑制小鼠鼻黏膜中Toll样信号通路的活化,降低IL-6和TNF-α的表达活性,从而改善了AR小鼠的炎症改变。

Abstract:

Objective: To study the key target genes and signaling pathways in the treatment of allergic rhinitis(AR) with radix aconiti lateralis preparata(aka Fuzi). Methods: The TCMPS and PubChem databases were used to screen the active ingredients and target genes of Fuzi using oral bioavailability and drug similarity as screening conditions, and the GeneCards database was used to screen the target genes of AR. The online tool Venny2.1 was used to screen the target genes of Fuzi for the treatment of Allergic Rhinitis; the STRING database was used to obtain the protein-protein interaction(PPI) network of drug-disease targets, and the key target genes were identified by the MCC algorithm. The potential biological processes and signaling pathways were identified by GO enrichment and KEGG enrichment analysis. Finally, animal experiments were conducted to demonstrate the therapeutic effect of Fuzi on allergic rhinitis. Results: The TCMSP, PubChem and GeneCards databases were used to screen the 21active compound components of Fuzi and 68 potential therapeutic target genes of Fuzi for Allergic Rhinitis. PPI network analysis identified the top ten key target genes, namely: PTGS2, TNF, IL6, AKT1, ALB, STAT3, CCL2, CXCL8, VEGFA and JUN. GO functional and KEGG pathway enrichment analysis showed that the significantly enriched functions and pathways of Fuzi on allergic rhinitis were closely related to allergic rhinitis. Finally, animal experiments were conducted to verify that Fuzi is effective in the treatment of allergic rhinitis. Conclusion: Increased expression of IL-6 and TNF-α in nasal mucosal tissues of patients with allergic rhinitis was positively correlated with indicators related to the disease activity of allergic rhinitis. Fuzi ameliorated the inflammatory changes in mice with allergic rhinitis by inhibiting the activation of toll-like signaling pathway in the nasal mucosa and decreasing the expression activity of IL-6 and TNF-α.

参考文献

1刘嘉咏,李越,谢宇锋,等.少阳枢机针法治疗变应性鼻炎临床研究[J].针灸临床杂志,2023,39(4):21-25.

2 Ebrahim N,Mandour YMH,Farid AS,et al.Adipose tissue-derived mesenchymal stem cell modulates the immune response of allergic rhinitis in a rat model[J].Int JMol Sci,2019,20(4):873.

3 Okubo K,Kurono Y,Ichimura K,et al.Japanese guidelines for allergic rhinitis 2020[J].Allergol Int,2020,69(3):331-345.

4马文玲,白丽君.变应性鼻炎的病因病机及治疗研究进展[J].中医眼耳鼻喉杂志,2022,12(4):215-222.

5 Pfaar O,Lou H,Zhang Y,et al.Recent developments and highlights in allergen immunotherapy[J].Allergy,2018,73(12):2274-2289.

6 Seth D,Kamat D.Intranasal steroid therapy for allergic rhinitis[J].Pediatr Ann,2019,48(1):e43-e48.

7忻耀杰,滕磊,魏慈芸,等.变应性鼻炎的中医诊疗心悟[J].中国中西医结合耳鼻咽喉科杂志,2018,26(3):163-165.

8 Zhou G,Tang L,Zhou X,et al.A review on phytochemistry and pharmacological activities of the processed lateral root of Aconitum carmichaelii Debeaux[J].JEthnopharmacol,2015,160:173-193.

9贺心宁,王小涔,田理.变应性鼻炎常用经方历史溯源与临床应用概况[J].中国民族民间医药,2023,32(8):59-62.

10 Ru J,Li P,Wang J,et al.TCMSP:A database of systems pharmacology for drug discovery from herbal medicines[J].J Cheminform,2014,6:13.

11 Ren Y,Nie L,Zhu S,et al.Nanovesicles-mediated drug delivery for oral bioavailability enhancement[J].Int J Nanomed,2022,17:4861-4877.

12 Kim S,Chen J,Cheng T,et al.Pub Chem in 2021:New data content and improved web interfaces[J].Nucleic Acids Res,2021,49(D1):D1388-D1395.

13 Wang Y,Wang Q,Huang H,et al.A crowdsourcing open platform for literature curation in Uni Prot[J].PLo S Biol,2021,19(12):e3001464.

14 Pi?ero J,Saüch J,Sanz F,et al.The Dis Ge NET cytoscape app:Exploring and visualizing disease genomics data[J].Comput Struct Biotechnol J,2021,19:2960-2967.

15 Wang F,Wang L,Liu F,et al.Investigation of the mechanism of the reduction of anthracycline-induced cardiotoxicity by Qishen Huanwu Capsule based on network pharmacology[J].Ann Palliat Med,2021,10(1):16-28.

16 Doncheva NT,Morris JH,Gorodkin J,et al.Cytoscape string App:Network analysis and visualization of proteomics data[J].J Proteome Res,2019,18(2):623-632.

17 Szklarczyk D,Gable AL,Nastou KC,et al.The STRING database in 2021:Customizable protein-protein networks,and functional characterization of user-uploaded gene/measurement sets[J].Nucleic Acids Res,2021,49(D1):D605-D612.

18 Zhou F,Xing Y,Cheng T,et al.Exploration of hub genes involved in PCOS using biological informatics methods[J].Medicine (Baltimore),2022,101(40):e30905.

19 Aleksander SA,Balhoff J,Carbon S,et al.The gene ontology knowledgebase in 2023[J].Genetics,2023,224(1):iyad031.

20 Kanehisa M,Furumichi M,Sato Y,et al.KEGG:Integrating viruses and cellular organisms[J].Nucleic Acids Res,2021,49(D1):D545-D551.

21 Sherman BT,Hao M,Qiu J,et al.DAVID:A web server for functional enrichment analysis and functional annotation of gene lists (2021 update)[J].Nucleic Acids Res,2022,50(W1):W216-W221.

22 Chicco D,Jurman G.A brief survey of tools for genomic regions enrichment analysis[J].Front Bioinform,2022,2:968327.

23 Long R,Zhou Y,Huang J,et al.Bencycloquidium bromide inhibits nasal hypersecretion in a rat model of allergic rhinitis[J].Inflamm Res,2015,64(3-4):213-223.

24 Okano M,Fujieda S,Gotoh M,et al.Executive summary:Japanese guidelines for allergic rhinitis 2020[J].Allergol Int,2023,72(1):41-53.

25 Wise SK,Lin SY,Toskala E,et al.International consensus statement on allergy and rhinology:Allergic rhinitis[J].Int Forum Allergy Rhinol,2018,8(2):108-352.

26 Yang B,Wang N,Wang S,et al.Network-pharmacology-based identi fi cation of caveolin-1 as a key target of Oldenlandia diffusa to suppress breast cancer metastasis[J].Biomed Pharmacother,2019,112:108607.

27 Hu KX,Duan X,Han LZ,et al.Exploring pharmacological mechanisms of Xiang Ju tablets in the treatment of allergic rhinitis via a network pharmacology approach[J].Evid Based Complement Alternat Med,2019,2019:6272073.

28 Zhang Y,Fu J,Zhou Z,et al.Exploring the relationship between allergic rhinitis and constitution based on the"Traditional Chinese Medicine Constitution Theory"[J].Evid Based Complement Alternat Med,2022,2022:9230317.

29 Liang X,Liu CS,Wei XH,et al.Mahuang Fuzi Xixin Decoction ameliorates allergic rhinitis in rats by regulating the gut microbiota and Th17/Treg balance[J].J Immunol Res,2020,2020:6841078.

30杨懿,吴威,李楠,等.应用经典名方治疗变应性鼻炎的方药统计及用药规律分析[J].药物评价研究,2021,44(9):1998-2006.

31兰欣.仲景经方辨治变应性鼻炎临床研究进展[J].实用中医药杂志,2021,37(5):897-899.

32 Fu YP,Zou YF,Lei FY,et al.Aconitum carmichaelii Debeaux:A systematic review on traditional use,and the chemical structures and pharmacological properties of polysaccharides and phenolic compounds in the roots[J].J Ethnopharmacol,2022,291:115148.

33 Zhou Z,Chen B,Chen S,et al.Applications of network pharmacology in traditional Chinese medicine research[J].Evid Based Complement Alternat Med,2020,2020:1646905.

34 Raman S,Murugaiyah V,Parumasivam T.Andrographis paniculata dosage forms and advances in nanoparticulate delivery systems:An overview[J].Molecules,2022,27(19):6164.

35 Mussard E,Jousselin S,Cesaro A,et al.Andrographis paniculata and its bioactive diterpenoids against inflammation and oxidative stress in keratinocytes[J].Antioxidants (Basel),2020,9(6):530.

36 Gan L,Zheng Y,Deng L,et al.Diterpenoid lactones with anti-inflammatory effects from the aerial parts of andrographis paniculata[J].Molecules,2019,24(15):2726.

37 Zhang W,Lian Y,Li Q,et al.Preventative and therapeutic potential of flavonoids in peptic ulcers[J].Molecules,2020,25(20):4626.

38 Gao J,Bao L,Zhang A.The mechanism underlying hypaconitine-mediated alleviation of pancreatitis-associated lung injury through up-regulating aquaporin-1/TNF-α[J].Turk J Gastroenterol,2020,31(11):790-798.

39 Alexanian A,Sorokin A.Cyclooxygenase 2:Proteinprotein interactions and posttranslational modifications[J].Physiol Genomics,2017,49(11):667-681.

40 Anamthathmakula P,Winuthayanon W.Prostaglandinendoperoxide synthase 2 (PTGS2) in the oviduct:Roles in fertilization and early embryo development[J].Endocrinology,2021,162(4):bqab025.

41 Webster JD,Vucic D.The balance of TNF mediated pathways regulates inflammatory cell death signaling in healthy and diseased tissues[J].Front Cell Dev Biol,2020,8:365.

42 Zhang Z,Yao L,Yang J,et al.PI3K/Akt and HIF-1signaling pathway in hypoxia-ischemia (Review)[J].Mol Med Rep,2018,18(4):3547-3554.

43 Ha H,Debnath B,Neamati N.Role of the CXCL8-CX-CR1/2 axis in cancer and inflammatory diseases[J].Theranostics,2017,7(6):1543-1588.

44 Sunitha P,Raju R,Sajil CK,et al.Temporal VEGFAresponsive genes in HUVECs:Gene signatures and potential ligands/receptors fine-tuning angiogenesis[J].JCell Commun Signal,2019,13(4):561-571.

45 Liu P,Xu H,Shi Y,et al.Potential molecular mechanisms of plantain in the treatment of gout and hyperuricemia based on network pharmacology[J].Evid Based Complement Alternat Med,2020,2020:3023127.

46 Korbecki J,Simińska D,G?ssowska-Dobrowolska M,et al.Chronic and cycling hypoxia:Drivers of cancer chronic inflammation through HIF-1 and NF-κB activation:A review of the molecular mechanisms[J].Int JMol Sci,2021,22(19):10701.

47 Joglekar AV,Leonard MT,Jeppson JD,et al.T cell antigen discovery via signaling and antigen-presenting bifunctional receptors[J].Nat Methods,2019,16(2):191-198.

48 Chen RX,Dai MD,Zhang QZ,et al.TLR signaling pathway gene polymorphisms,gene-gene and gene-environment interactions in allergic rhinitis[J].J Inflam Res,2022,15:3613-3630.

49 Michels KR,Lukacs NW,Fonseca W.TLR activation and allergic disease:Early life microbiome and treatment[J].Curr Allergy Asthma Rep,2018,18(11):61.

50 Kirtland ME,Tsitoura DC,Durham SR,et al.Tolllike receptor agonists as adjuvants for allergen immunotherapy[J].Front Immunol,2020,11:599083.

基本信息:

DOI:10.13210/j.cnki.jhmu.20230616.003

中图分类号:R285.5

引用信息:

[1]李琳,丁顺,徐正扬,等.基于网络药理学和实验验证探讨附子治疗变应性鼻炎的作用机制研究[J].海南医学院学报,2023,29(15):1162-1172.DOI:10.13210/j.cnki.jhmu.20230616.003.

基金信息:

海南省自然科学基金项目(820RC627)~~

发布时间:

2023-06-19

出版时间:

2023-06-19

网络发布时间:

2023-06-19

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文